Falling interest rates should be good news for India's prospective new asset class — infrastructure investment trusts — as long as issuers price the first few deals to perform.
Korean conglomerate is paying $530 million to acquire a controlling 51% stake in silicon wafer manufacturer LG Siltron.
The bank seeks funding from shareholders to strengthen its balance sheet before tighter capital requirements come into force in 2019.
The diagnostics company takes a realistic approach to pricing as foreign investors turn net sellers across Southeast Asia.
The Swiss firm has recruited its first private bank chief in Shanghai, as it continues to build out local businesses in Asia. But it's not clear whether it's still seeking mainland partners.
Indonesia's largest diagnostics company launches its flotation on schedule as equity markets remain buoyant following Donald Trump's unexpected election success.
Steven Zhang joins Credit Suisse Founder Securities as the firm launches its securities brokerage business.
Korean chaebol accepts an IPO price that values Bobcat at barely half the cost of the original 2007 acquisition.
Investors piled into the biologic drug manufacturer’s listing despite a young corporate history and an unimpressive track record of generating profits.
The Chinese fast-food retailer hopes its unique business model will help secure a valuation premium to its peers when it lists in Hong Kong next month.
Datang Environment, FIT Hon Teng and Shanghai Dazhong look to raise over $1 billion from listings in November. For investors, they offer a change after a run of financial IPOs.
Shanghai-based delivery firm opts for an IPO in the US, taking a different route from its major competitors.
Korea’s largest IPO of the year has been put on hold after investors balked at the valuation and worried about the US election.
Pakistan returns with record breaking sukuk, while Indian agro-chemicals company makes its offshore debut.
South Korea’s biggest conglomerate sets out with ambitious plans to raise as much as $2 billion from the listing of its contract drug unit on the Korean stock market.
If it delivers the same upside as the sector's last IPO, investors will be very happy.
The Singapore-based healthcare services provider’s upcoming listing is being billed as one of the city's most exciting equity growth stories in years.
Chinese issuers descend on force ahead of almost week-long public holidays across Asia.
Co-founder Cai Kui sold shares in the Chinese property developer for the first time since resigning from a company management role in 2009.
It has been a long time coming but the hotels, property investment and car park group finally makes its debut in dollars.